Olmesartan Medoxomil And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 65862-780

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil And Hydrochlorothiazide (NDC 65862-780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (20 mg/12.5 mg (30 Tablets Bottle))

Label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets 20 mg/12.5 mg, film-coated, from Aurobindo Pharma Limited. The label indicates 30 tablets per package, dosing instructions, storage conditions, and distributor information for Aurobindo Pharma USA, Inc. It includes a barcode and regulatory details such as NDC and manufacturing origin in India.*

FDA Label Image

Package Label-principal Display Panel (20 mg/12.5 mg Blister Carton (10 x 10 Unit-dose))

Packaging label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 20 mg/12.5 mg film-coated tablets. The label shows a 100 count (10 x 10) unit-dose tablet package by Aurobindo Pharma USA, Inc. The label includes storage instructions, a barcode, and states the product is Rx only. The tablets contain 20 mg Olmesartan Medoxomil and 12.5 mg Hydrochlorothiazide, distributed by Aurobindo Pharma USA, made in India.*

FDA Label Image

Package Label-principal Display Panel (40 mg/12.5 mg (30 Tablets Bottle))

Label for Olmesartan Medoxomil and Hydrochlorothiazide tablets 40 mg/12.5 mg film-coated tablet. The label shows the product name with strength, specifies 30 tablets per package, and includes the distributor Aurobindo Pharma USA, Inc. Address and storage instructions (20° to 25°C). The label also includes the NDC number 65862-780-30 and a barcode.*

FDA Label Image

Package Label-principal Display Panel (40 mg/12.5 mg Blister Carton (10 x 10 Unit-dose))

Packaging label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/12.5 mg, film-coated tablets. The label shows a unit-dose package containing 100 tablets (10 x 10), distributed by Aurobindo Pharma USA, Inc. and made in India. The label includes storage instructions and states the package is not child resistant.*

FDA Label Image

Package Label-principal Display Panel (40 mg/25 mg (30 Tablets Bottle))

Label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg by Aurobindo Pharma Limited, containing 30 film-coated tablets. The label provides storage instructions, distributor information, and indicates the product is made in India. The label includes an NDC number and barcode.*

FDA Label Image

Package Label-principal Display Panel (40 mg/25 mg Blister Carton (10 x 10 Unit-dose))

Packaging label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 40 mg/25 mg strength. The label shows the product name, dosage strength, quantity of 100 (10 x 10) unit-dose tablets, and indicates the tablets are film-coated. It also includes storage instructions and distributor information for Aurobindo Pharma USA, Inc. The label features the NDC 65862-781-78 and states the product is made in India by Aurobindo Pharma Limited.*

FDA Label Image

Chemical Structure1 (Olmehctz Str1)

Chemical structure diagram of Olmesartan Medoxomil, showing its molecular arrangement with labeled atoms and bonds.*

FDA Label Image

Chemical Structure2 (Olmehctz Str2)

Chemical structure of Olmesartan Medoxomil and Hydrochlorothiazide. The diagram shows the molecular framework including functional groups and atoms forming the chemical compound used in the pharmaceutical product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.